GLP-1-based therapies and resmetirom operate through distinct and potentially complementary mechanisms: while resmetirom exerts direct hepatic effects by activating THR- to enhance mitochondrial function, reduce hepatic lipogenesis, and promote lipid oxidation specifically in hepatocytes, GLP-1 RAs and multi-agonists address the upstream metabolic drivers of MASLD including insulin resistance, obesity, and systemic inflammation
What is the origin of DSIP
Diabesity in the Arabian Gulf: challenges and opportunities
Ipamorelin They help stimulate the bodys natural production of growth hormone, which may support recovery, sleep quality, body composition, and overall wellness
L-Carnitine works by helping the body utilize fatty acids and convert them into usable fuel, helping you burn fat during workouts